Influence of major structural features of tocopherols and tocotrienols on their ω-oxidation by tocopherol-ω-hydroxylase

Journal of Lipid Research

Volumn 48, Issue 5, 2007, Pages 1090-1098

  Sontag, Timothy J ^a   Parker, Robert S ^a  

^a Cornell University ^*  (United States)

Author keywords

Cytochrome P450; HepG2; Hydroxylation; Kinetics; Metabolism; Microsome; Uptake; Vitamin E

Indexed keywords

ALKANE 1 MONOOXYGENASE; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; CYTOCHROME P450; CYTOCHROME P450 4F2; TOCOPHEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN HEPG2; CONTROLLED STUDY; FATTY ACID OMEGA OXIDATION; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIVER MICROSOME; METHYLATION; MICHAELIS MENTEN KINETICS; MICROSOME MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY; VITAMIN METABOLISM;

CELL LINE, TUMOR; HUMANS; KINETICS; MICROSOMES; MIXED FUNCTION OXYGENASES; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; SUBSTRATE SPECIFICITY; TOCOPHEROLS; TOCOTRIENOLS; VITAMIN E;

EID: 34248198290     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600514-JLR200     Document Type: Article

References (54)

1. Kamal-Eldin, A., and L. A. Appelqvist. 1996. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids. 31: 671-701.
2. Burton, G. W., and K. U. Ingold. 1986. Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function. Acc. Chem. Res. 19: 194-201.
3. Yamashita, K., Y. Nohara, K. Katayama, and M. Namiki. 1992. Sesame seed lignans and gamma-tocopherol act synergistically to produce vitamin E activity in rats. J. Nutr. 122: 2440-2446.
4. Serbinova, E., V. Kagan, D. Han, and L. Packer. 1991. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic. Biol. Med. 10: 263-275.
5. Saito, Y., Y. Yoshida, T. Akazawa, K. Takahashi and E. Niki. 2003. Cell death caused by selenium deficiency and protective effect of antioxidants. J. Biol. Chem. 278: 39428-39434.
6. Yoshida, Y., E. Niki, and N. Noguchi. 2003. Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem. Phys. Lipids. 123: 63-75.
7. Suarna, C., R. L. Hood, R. T. Dean, and R. Stocker. 1993. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim. Biophys. Acta. 1166: 163-170.
8. Hoglen, N. C., S. C. Waller, I. G. Sipes, and D. C. Liebler. 1997. Reactions of peroxynitrite with gamma-tocopherol. Chem. Res. Toxicol. 10: 401-407.
9. Williamson, K. S., S. P. Gabbita, S. Mou, M. West, Q. N. Pye, W. R. Markesbery, R. V. Cooney, P. Grammas, U. Reimann-Philipp, R. A. Floyd, et al. 2002. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide. 6: 221-227.
10. Boscoboinik, D., A. Szewczyk, C. Hensey, and A. Azzi. 1991. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266: 6188-6194.
11. Tasinato, A., D. Boscoboinik, G. M. Bartoli, P. Maroni, and A. Azzi. 1995. d-Alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. USA. 92: 12190-12194.
12. Ricciarelli, R., J. M. Zingg, and A. Azzi. 2000. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation. 102: 82-87.
13. Keaney, J. F., Jr., D. I. Simon, and J. E. Freedman. 1999. Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J. 13: 965-975.
14. Jiang, Q., I. Elson-Schwab, C. Courtemanche, and B. N. Ames. 2000. Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. USA. 97: 11494-11499.
15. Parker, R. A., B. C. Pearce, R. W. Clark, D. A. Gordon, and J. J. Wright. 1993. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 268: 11230-11238.
16. Yu, W., M. Simmons-Menchaca, A. Gapor, B. G. Sanders, and K. Kline. 1999. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer. 33: 26-32.
17. Qureshi, A. A., H. Mo, L. Packer, and D. M. Peterson. 2000. Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties. J. Agric. Food Chem. 48: 3130-3140.
18. McIntyre, B. S., K. P. Briski, M. A. Tirmenstein, M. W. Fariss, A. Gapor, and P. W. Sylvester. 2000. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids. 35: 171-180.
19. Traber, M. G., and H. J. Kayden. 1989. Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins. Am. J. Clin. Nutr. 49: 517-526.
20. Burton, G. W., M. G. Traber, R. V. Acuff, D. N. Walters, H. Kayden, L. Hughes, and K. U. Ingold. 1998. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am. J. Clin. Nutr. 67: 669-684.
21. Panagabko, C., S. Morley, M. Hernandez, P. Cassolato, H. Gordon, R. Parsons, D. Manor, and J. Atkinson. 2003. Ligand specificity in the CRAL-TRIO protein family. Biochemistry. 42: 6467-6474.
22. Arita, M., K. Nomura, H. Arai, and K. Inoue. 1997. Alpha-tocopherol transfer protein stimulates the secretion of alpha-tocopherol from a cultured liver cell line through a brefeldin A-insensitive pathway. Proc. Natl. Acad. Sci. USA. 94: 12437-12441.
23. Morinobu, T., S. Yoshikawa, K. Hamamura, and H. Tamai. 2003. Measurement of vitamin E metabolites by high-performance liquid chromatography during high-dose administration of alpha-tocopherol. Eur. J. Clin. Nutr. 57: 410-414.
24. Kaneko, K., C. Kiyose, T. Ueda, H. Ichikawa, and O. Igarashi. 2000. Studies of the metabolism of alpha-tocopherol stereoisomers in rats using [5-methyl-(14)C]SRR- and RRR-alpha-tocopherol. J. Lipid Res. 41: 357-367.
25. Schonfeld, A., M. Schultz, M. Petrizka, and B. Gassmann. 1993. A novel metabolite of RRR-alpha-tocopherol in human urine. Nahrung. 37: 498-500.
26. Wechter, W. J., D. Kantoci, E. D. Murray, Jr., D. C. D'Amico, M. E. Jung, and W. H. Wang. 1996. A new endogenous natriuretic factor: LLU-alpha. Proc. Natl. Acad. Sci. USA. 93: 6002-6007.
27. Chiku, S., K. Hamamura, and T. Nakamura. 1984. Novel urinary metabolite of d-delta-tocopherol in rats. J. Lipid Res. 25: 40-48.
28. Hattori, A., T. Fukushima, H. Yoshimura, K. Abe, and K. Imai. 2000. Production of LLU-alpha following an oral administration of gamma-tocotrienol or gamma-tocopherol to rats. Biol. Pharm. Bull. 23: 1395-1397.
29. Lodge, J. K., J. Ridlington, S. Leonard, H. Vaule, and M. G. Traber. 2001. Alpha- and gamma-tocotrienols are metabolized to carboxy-ethyl- hydroxychroman derivatives and excreted in human urine. Lipids. 36: 43-48.
30. Sontag, T. J., and R. S. Parker. 2002. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism: novel mechanism of regulation of vitamin E status. J. Biol. Chem. 277: 25290-25296.
31. Birringer, M., D. Drogan, and R. Brigelius-Flohe. 2001. Tocopherols are metabolized in HepG2 cells by side chain omega-oxidation and consecutive beta-oxidation. Free Radic. Biol. Med. 31: 226-232.
32. Kikuta, Y., E. Kusunose, T. Kondo, S. Yamamoto, H. Kinoshita, and M. Kusunose. 1994. Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. FEBS Lett. 348: 70-74.
33. Handelman, G. J., L. J. Machlin, K. Fitch, J. J. Weiter, and E. A. Dratz. 1985. Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. J. Nutr. 115: 807-813.
34. Sen, C. K., S. Khanna, S. Roy, and L. Packer. 2000. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamateinduced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J. Biol. Chem. 275: 13049-13055.
35. Takakuwa, Y., H. Nishino, Y. Ishibe, and T. Ishibashi. 1994. Properties and kinetics of membrane-bound enzymes when both the enzyme and substrate are components of the same microsomal membrane. Studies on lathosterol 5-desaturase. J. Biol. Chem. 269: 27889-27893.
36. Zhang, Y., C. Yu, J. Liu, T. A. Spencer, C. C. Y. Chang, and T-Y. Chang. 2003. Cholesterol is superior to 7-ketocholesterol or 7α- hydroxycholesterol as an allosteric activator for acyl-coenzyme A:cholesterol acyltransferase 1. J. Biol. Chem. 278: 11642-11647.
37. Traber, M. G., G. W. Burton, K. U. Ingold, and H. J. Kayden. 1990. RRR- and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins. J. Lipid Res. 31: 675-685.
38. Kikuta, Y., Y. Miyauchi, E. Kusunose, and M. Kusunose. 1999. Expression and molecular cloning of human liver leukotriene B4 omega-hydroxylase (CYP4F2) gene. DNA Cell Biol. 18: 723-730.
39. Yamane, M., and A. Abe. 2000. Omega-hydroxylation activity toward leukotriene B(4) and polyunsaturated fatty acids in the human hepatoblastoma cell line, HepG2, and human lung adenocarcinoma cell line, A549. J. Biochem. (Tokyo). 128: 827-835.
40. Grau, A., and A. Ortiz. 1998. Dissimilar protection of tocopherol isomers against membrane hydrolysis by phospholipase A2. Chem. Phys. Lipids. 91: 109-118.
41. Kikuta, Y., E. Kusunose, and M. Kusunose. 2000. Characterization of human liver leukotriene B(4) omega-hydroxylase P450 (CYP4F2). J. Biochem. (Tokyo). 127: 1047-1052.
42. Jin, R., D. R. Koop, J. L. Raucy, and J. M. Lasker. 1998. Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. Arch. Biochem. Biophys. 359: 89-98.
43. Houston, J. B., and K. E. Kenworthy. 2000. In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. Drug Metab. Dispos. 28: 246-254.
44. Shou, M., J. Grogan, J. A. Mancewicz, K. W. Krausz, F. J. Gonzalez, H. V. Gelboin, and K. R. Korzekwa. 1994. Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry. 33: 6450-6455.
45. Shou, M., Q. Mei, M. W. Ettore, Jr., R. Dai, T. A. Baillie, and T. H. Rushmore. 1999. Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives. Biochem. J. 340: 845-853.
46. Harlow, G. R., and J. R. Halpert. 1998. Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics. Proc. Natl. Acad. Sci. USA. 95: 6636-6641.
47. Hlavica, P., and D. F. V. Lewis. 2001. Allosteric phenomena in cytochrome P450-catalyzed monooxygenations. Eur. J. Biochem. 268: 4817-4832.
48. Bisby, R. H., and D. J. Birch. 1989. A time-resolved fluorescence anisotropy study of bilayer membranes containing alpha-tocopherol. Biochem. Biophys. Res. Commun. 158: 386-391.
49. Fukuzawa, K., H. Chida, and A. Suzuki. 1980. Fluorescence depolarization studies of phase transition and fluidity in lecithin liposomes containing alpha-tocopherol. J. Nutr. Sci. Vitaminol. (Tokyo). 26: 427-434.
50. Straka, M. S., L. H. Junker, L. Zacarro, D. L. Zogg, S. Deuland, G. T. Everson, and R. A. Davis. 1990. Substrate stimulation of 7α-hydroxylase, an enzyme located in the cholesterol-poor endoplasmic reticulum. J. Biol. Chem. 265: 7145-7149.
51. Scheel, G., E. Acevedo, D. Conzelmann, H. Nehrkorn, and K. Sandhoff. 1982. Model for the interaction of membrane-bound substrates. Hydrolysis of ganglioside GD1a by sialidase of neuronal membranes isolated from calf brain. Eur. J. Biochem. 127: 245-253.
52. Kiyose, C., H. Saito, K. Kaneko, K. Hamamura, M. Tomioka, T. Ueda, and O. Igarashi. 2001. Alpha-tocopherol affects the urinary and biliary excretion of 2,7,8-trimethyl-2 (2′-carboxyethyl)-6-hydroxychroman, gamma-tocopherol metabolite, in rats. Lipids. 36: 467-472.
53. Terasawa, Y., Z. Ladha, S. W. Leonard, J. D. Morrow, D. Newland, D. Sanan, L. Packer, M. G. Traber, and R. V. Farese, Jr. 2000. Increased atherosclerosis in hyperlipidemic mice deficient in alpha-tocopherol transfer protein and vitamin E. Proc. Natl. Acad. Sci. USA. 97: 13830-13834.
54. Parker, R. S., and C. C. McCormick. 2005. Selective accumulation of alpha-tocopherol in Drosophila melanogaster is associated with tocopherol-ω-hydroxylase activity but not with tocopherol transfer protein. Biochem. Biophys. Res. Commun. 338: 1537-1541.